Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint inhibitors in liver transplant: a case series
Mark Rudolph, Shimul A. Shah, Ralph C. Quillin, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 2, pp. 1141-1148
Open Access | Times Cited: 21

Showing 21 citing articles:

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis
Mohammad Saeid Rezaee‐Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 27
Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data
Charles‐Henri Wassmer, Sofia El Hajji, Xenofon Papazarkadas, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4574-4574
Open Access | Times Cited: 23
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report
Pramod Kumar, Pradeep Krishna, Ravindra Nidoni, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 6, pp. 1087-1090
Closed Access | Times Cited: 10
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 6
Liver Transplantation for Non-Hepatocellular Carcinoma: Role of Immune Checkpoint Inhibitors
Pegah Bahrami, Mohammad Al Zein, Ali H. Eid, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102558-102558
Closed Access
Transplant oncology – Current indications and strategies to advance the field
Felix J. Krendl, Ruben Bellotti, Gonzalo Sapisochín, et al.
JHEP Reports (2023) Vol. 6, Iss. 2, pp. 100965-100965
Open Access | Times Cited: 11
Personalized treatment approaches in hepatocellular carcinoma
Ahmed Ramadan, Mona Kaddah, Hend Ibrahim Shousha, et al.
Arab Journal of Gastroenterology (2025) Vol. 26, Iss. 1, pp. 122-128
Closed Access
Immune Checkpoint Inhibitors and Liver Transplantation: Case Report and Review of the Literature
Iva Skočilić, Alojzije Košić, Ivona Badovinac, et al.
Clinical Case Reports (2025) Vol. 13, Iss. 4
Open Access
The effect of liver disease on hepatic microenvironment and implications for immune therapy
Zachary J. Brown, Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Fatal graft-versus-host disease in recipient with pretransplant exposure to immune checkpoint inhibitors and donor-dominant one-way HLA matching after liver transplantation: A case report
Li Pang, Wenrui Wu, Lei-Bo Xu, et al.
International Journal of Surgery Case Reports (2024), pp. 110267-110267
Open Access | Times Cited: 2
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future
Hao Liu, Vrishketan Sethi, Xingjie Li, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 079-098
Closed Access | Times Cited: 1
Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Nicola De Stefano, Damiano Patrono, Fabio Colli, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2374-2374
Open Access | Times Cited: 1
Liver Resection and Transplantation in the Era of Checkpoint Inhibitors
Parissa Tabrizian, Rebecca Marino, Pierce K. H. Chow
JHEP Reports (2024) Vol. 6, Iss. 11, pp. 101181-101181
Open Access | Times Cited: 1
Immunotherapy Prior to a Liver Transplant: Literature Review and a Case Report of Hepatocellular Carcinoma With BRCA1 Mutation
N. E. Kostrygin, D. S. Chumachenko
Innovative medicine of Kuban (2024), Iss. 3, pp. 61-69
Open Access | Times Cited: 1
Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy
Parissa Tabrizian, Marcus Zeitlhoefler, Ahmed Talaat Hassan, et al.
Current Opinion in Organ Transplantation (2023) Vol. 29, Iss. 2, pp. 144-154
Closed Access | Times Cited: 3
Patients treated with immune checkpoint inhibitors for HCC should not be considered for liver transplant
Frances Lee, Ann K. Robinson, Edward Will Holt, et al.
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access
Risk of transplant rejection associated with ICIs prior to liver transplantation in HCC: A multicenter retrospective study
Ye Xu, Yan Yan, Donghua Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113400-113400
Closed Access
Role of immunotherapy in managing cancers prior to liver transplantation
Philip Bredin, Zita Galvin, Grainne M. O’Kane
Current Opinion in Organ Transplantation (2024)
Closed Access
Harnessing the Power of Immunotherapy in Liver Transplantation for HCC
Dalal Alhaqqan, Yii Chun Khiew, Maryam Dadashzadeh, et al.
Current Transplantation Reports (2024) Vol. 11, Iss. 3, pp. 131-139
Closed Access
Transplant oncology: Concept, history, and evolution
Vincenzo Mazzaferro, Marianna Maspero, Carlo Sposito
Elsevier eBooks (2024), pp. 3-15
Closed Access
Suppressing, stimulating and/or inhibiting: the evolving management of HCC patient after liver transplantation
Lorenza Di Marco, Adriana Romanzi, Alessandra Pivetti, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104607-104607
Closed Access
Multiple drugs

Reactions Weekly (2023) Vol. 1967, Iss. 1, pp. 282-282
Closed Access
Page 1

Scroll to top